CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA

Clinical trials for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA explained in plain language.

Never miss a new study

Get alerted when new CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA trials appear

Sign up with your email to follow new studies for CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

Drug aims to keep cancer treatment on track by boosting platelets

Disease control Completed

This study tested whether a drug called romiplostim could help patients with gastrointestinal, pancreatic, or colorectal cancer stay on their planned chemotherapy schedule. Chemotherapy can cause dangerously low platelet counts (thrombocytopenia), which often forces doctors to de…

Matched conditions: CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA

Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control

Last updated Apr 02, 2026 00:56 UTC

CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA

Get alerted when new CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA trials appear

Drug aims to keep cancer treatment on track by boosting platelets